Vijaya Bharti

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists

Jessalyn J. Baljon, Alexander J. Kwiatkowski, Hayden M. Pagendarm et al. · ACS Nano · 2024 · 105 citations · Full text

Life Sciences, Immunology, Oncology +17

Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors

Roman V. Uzhachenko, Vijaya Bharti, Zhufeng Ouyang et al. · Cell Reports · 2021 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids

Anna E. Vilgelm, Kensey Bergdorf, Melissa M. Wolf et al. · iScience · 2020 · 78 citations · Full text

Medicine, Cancer Biology, Oncology +9

BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis

Vijaya Bharti, Reese Watkins, Amrendra Kumar et al. · Cell Reports · 2022 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +14

Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition

Rebecca L. Shattuck-Brandt, Sheau‐Chiann Chen, Emily Murray et al. · Clinical Cancer Research · 2020 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17